VOLITIONRX LTD (VNRX) Stock Fundamental Analysis

USA • NYSE Arca • NYSEARCA:VNRX • US9286611077

0.247 USD
-0.01 (-4.96%)
At close: Feb 5, 2026
0.2548 USD
+0.01 (+3.16%)
After Hours: 2/5/2026, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VNRX. VNRX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. VNRX may be in some trouble as it scores bad on both profitability and health. VNRX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • VNRX had negative earnings in the past year.
  • VNRX had a negative operating cash flow in the past year.
  • In the past 5 years VNRX always reported negative net income.
  • VNRX had a negative operating cash flow in each of the past 5 years.
VNRX Yearly Net Income VS EBIT VS OCF VS FCFVNRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of VNRX (-267.93%) is worse than 91.94% of its industry peers.
Industry RankSector Rank
ROA -267.93%
ROE N/A
ROIC N/A
ROA(3y)-192.89%
ROA(5y)-150.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VNRX Yearly ROA, ROE, ROICVNRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VNRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VNRX Yearly Profit, Operating, Gross MarginsVNRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • VNRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VNRX has more shares outstanding
  • The number of shares outstanding for VNRX has been increased compared to 5 years ago.
  • The debt/assets ratio for VNRX is higher compared to a year ago.
VNRX Yearly Shares OutstandingVNRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
VNRX Yearly Total Debt VS Total AssetsVNRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • VNRX has an Altman-Z score of -47.92. This is a bad value and indicates that VNRX is not financially healthy and even has some risk of bankruptcy.
  • VNRX has a worse Altman-Z score (-47.92) than 90.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -47.92
ROIC/WACCN/A
WACC10.05%
VNRX Yearly LT Debt VS Equity VS FCFVNRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.35 indicates that VNRX may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.35, VNRX is doing worse than 93.01% of the companies in the same industry.
  • A Quick Ratio of 0.35 indicates that VNRX may have some problems paying its short term obligations.
  • VNRX has a Quick ratio of 0.35. This is amonst the worse of the industry: VNRX underperforms 93.01% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
VNRX Yearly Current Assets VS Current LiabilitesVNRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • VNRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.11%, which is quite impressive.
  • VNRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.10%.
  • VNRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 128.05% yearly.
EPS 1Y (TTM)36.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)59.1%
Revenue growth 3Y139.31%
Revenue growth 5Y128.05%
Sales Q2Q%32.19%

3.2 Future

  • VNRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.40% yearly.
  • Based on estimates for the next years, VNRX will show a very strong growth in Revenue. The Revenue will grow by 149.33% on average per year.
EPS Next Y29.96%
EPS Next 2Y26.69%
EPS Next 3Y30.17%
EPS Next 5Y41.4%
Revenue Next Year5.02%
Revenue Next 2Y133.78%
Revenue Next 3Y206.25%
Revenue Next 5Y149.33%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VNRX Yearly Revenue VS EstimatesVNRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
VNRX Yearly EPS VS EstimatesVNRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • VNRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VNRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VNRX Price Earnings VS Forward Price EarningsVNRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VNRX Per share dataVNRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

  • VNRX's earnings are expected to grow with 30.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.69%
EPS Next 3Y30.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for VNRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VOLITIONRX LTD

NYSEARCA:VNRX (2/5/2026, 8:04:00 PM)

After market: 0.2548 +0.01 (+3.16%)

0.247

-0.01 (-4.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners21.28%
Inst Owner Change-0.01%
Ins Owners6.49%
Ins Owner Change10.78%
Market Cap30.33M
Revenue(TTM)1.23M
Net Income(TTM)-23.32M
Analysts78.33
Price Target2.21 (794.74%)
Short Float %1.1%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.18%
Min EPS beat(2)-30.72%
Max EPS beat(2)-17.65%
EPS beat(4)1
Avg EPS beat(4)-12.18%
Min EPS beat(4)-30.72%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)7
Avg EPS beat(12)1.45%
EPS beat(16)8
Avg EPS beat(16)-55.27%
Revenue beat(2)1
Avg Revenue beat(2)-33.04%
Min Revenue beat(2)-71.37%
Max Revenue beat(2)5.28%
Revenue beat(4)1
Avg Revenue beat(4)-42.14%
Min Revenue beat(4)-73.81%
Max Revenue beat(4)5.28%
Revenue beat(8)1
Avg Revenue beat(8)-43%
Revenue beat(12)1
Avg Revenue beat(12)-45.6%
Revenue beat(16)1
Avg Revenue beat(16)-50.84%
PT rev (1m)0%
PT rev (3m)-35.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.22%
EPS NY rev (3m)-9.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-63.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.01
BVpS-0.26
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -267.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-192.89%
ROA(5y)-150.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.07%
Cap/Sales 31.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -47.92
F-Score4
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)104.21%
Cap/Depr(5y)136.83%
Cap/Sales(3y)230.92%
Cap/Sales(5y)4234.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y29.96%
EPS Next 2Y26.69%
EPS Next 3Y30.17%
EPS Next 5Y41.4%
Revenue 1Y (TTM)59.1%
Revenue growth 3Y139.31%
Revenue growth 5Y128.05%
Sales Q2Q%32.19%
Revenue Next Year5.02%
Revenue Next 2Y133.78%
Revenue Next 3Y206.25%
Revenue Next 5Y149.33%
EBIT growth 1Y28.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.89%
OCF growth 3YN/A
OCF growth 5YN/A

VOLITIONRX LTD / VNRX FAQ

What is the ChartMill fundamental rating of VOLITIONRX LTD (VNRX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to VNRX.


What is the valuation status of VOLITIONRX LTD (VNRX) stock?

ChartMill assigns a valuation rating of 1 / 10 to VOLITIONRX LTD (VNRX). This can be considered as Overvalued.


Can you provide the profitability details for VOLITIONRX LTD?

VOLITIONRX LTD (VNRX) has a profitability rating of 0 / 10.